Stay updated on Reslizumab in EGPA: Clinical Trial

Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reslizumab in EGPA: Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added a dedicated 'Locations' section featuring the Colorado site. Removed the old 'Colorado Locations' entry and the 'HHS Vulnerability Disclosure' link from the footer.
    Difference
    0.2%
    Check dated 2025-12-17T20:17:39.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    The PubMed publications note has been updated to say that publications are automatically filled from PubMed and may not be about the study. The revision label has been updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-26T08:41:14.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The funding-status notice banner was removed from the page, eliminating the warning about potential delays in updates due to government funding. The study details and other content remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-19T08:09:51.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    No significant changes observed between the old and new Study Details pages. Core study information and navigation remain the same.
    Difference
    0.5%
    Check dated 2025-10-28T02:47:00.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    4%
    Check dated 2025-10-06T15:52:00.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    - Version updated from v3.0.2 to v3.1.0. - New contact details added: multiple phone numbers and an email.
    Difference
    0.1%
    Check dated 2025-09-29T09:50:00.000Z thumbnail image

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.